Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancerWei Wen, John H. Yim|Molecular Cancer|2015Cited by 93
IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibitionMichaele J. Armstrong, John H. Yim|Cancer Biology & Therapy|2015Cited by 35
Combination therapy with BYL719 and LEE011 is synergistic and causes a greater suppression of p-S6 in triple negative breast cancerYuan Yuan, John H. Yim|Scientific Reports|2019Cited by 33
Therapeutic Potential of Baicalein in Endometrial Cancer: Suppression of mTOR Signaling and Synergy with MetforminAlison Wong, John H. Yim|International Journal of Molecular Sciences|2025Cited by 2